Localized bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor treatment

被引：4
|
作者：
Oya, Kazumasa [1 ]
Fujii, Masanao [2 ]
Taguchi, Shijima [1 ]
Nishie, Wataru [3 ]
Izumi, Kentaro [3 ]
Shimizu, Hiroshi [3 ]
机构：
[1] Mito Kyodo Gen Hosp, Div Dermatol, Tokyo, Japan
[2] Mito Kyodo Gen Hosp, Dept Endocrinol & Diabet, Tokyo, Japan
[3] Hokkaido Univ, Dept Dermatol, Grad Sch Med, Sapporo, Hokkaido, Japan
来源：
EUROPEAN JOURNAL OF DERMATOLOGY | 2018年 / 28卷 / 02期
关键词：
PHARMACOVIGILANCE DATABASE; IV INHIBITORS;
D O I：
10.1684/ejd.2018.3230
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
下载
收藏
页码：250 / 251
页数：2
相关论文
共 50 条
  • [41] The effect of dipeptidyl peptidase-4 inhibitor on incidence and clinical course in bullous pemphigoid patients in a tertiary medical center
    Hsu, Yu-Han Alice
    Yang, Ting-Ting
    Huang, Shu-Mei
    Lan, Cheng-Che Eric
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2023, 39 (10): : 1038 - 1044
  • [42] Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid showing positive autoantibody responses to multiple epitopes
    Kitao, Rikuma
    Fukumoto, Takeshi
    Hashimoto, Takashi
    Izumi, Kentaro
    Jimbo, Haruki
    Takemori, Chihiro
    Nishigori, Chikako
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2021, 103 (03) : 190 - 192
  • [43] Dipeptidyl Peptidase-4 Inhibitor-Related Bullous Pemphigoid: Clinical, Laboratory, and Histological Features, and Possible Pathogenesis
    Hung, Chih-Tsung
    Chang, Yung-Lung
    Wang, Wei-Ming
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [44] Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population
    Plaquevent, Marthe
    Tetart, Florence
    Fardet, Laurence
    Ingen-Housz-Oro, Saskia
    Valeyrie-Allanore, Laurence
    Bernard, Philippe
    Hebert, Vivien
    Roussel, Aude
    Avenel-Audran, Martine
    Chaby, Guillaume
    D'Incan, Michel
    Ferrier-Le-Bouedec, Marie-Christine
    Duvert-Lehembre, Sophie
    Picard-Dahan, Catherine
    Jeudy, Geraldine
    Collet, Evelyne
    Labeille, Bruno
    Morice, Cecile
    Richard, Marie-Aleth
    Bourgault-Villada, Isabelle
    Litrowski, Noemie
    Bara, Corina
    Mahe, Emmanuel
    Prost-Squarcioni, Catherine
    Alexandre, Marina
    Quereux, Gaelle
    Bernier, Claire
    Soria, Angele
    Thomas-Beaulieu, Domitille
    Pauwels, Christine
    Dereure, Olivier
    Benichou, Jacques
    Joly, Pascal
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (04) : 835 - 841
  • [45] Clinical Features and Outcomes of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid (DPP4i-Associated BP) in Thai Patients
    Thewjitcharoen, Yotsapon
    Wanothayaroj, Ekgaluck
    Thammawiwat, Chattip
    Porramatikul, Sriurai
    Vorayingyong, Chuleekorn
    Nakasatien, Soontaree
    Krittiyawong, Sirinate
    Chanprapaph, Kumutnart
    Himathongkam, Thep
    CASE REPORTS IN ENDOCRINOLOGY, 2020, 2020
  • [46] Commentary on 'Changing prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase-4 inhibitors'
    Fania, L.
    Di Zenzo, G.
    Mazzanti, C.
    Abeni, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (12) : E439 - E440
  • [47] Clinical and immunological characterization of 14 cases of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: a single-centre study
    Hayashi, M.
    Tsunoda, T.
    Sato, F.
    Yaguchi, Y.
    Igarashi, M.
    Izumi, K.
    Nishie, W.
    Ishii, N.
    Okamura, K.
    Suzuki, T.
    Hashimoto, T.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (03) : 806 - 807
  • [48] Detection and characterization of IgG, IgE, and IgA autoantibodies in patients with bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors
    Fania, Luca
    Salemme, Adele
    Provini, Alessia
    Pagnanelli, Gianluca
    Collina, Maria Chiara
    Abeni, Damiano
    Didona, Biagio
    Di Zenzo, Giovanni
    Mazzanti, Cinzia
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (03) : 592 - 595
  • [49] Dipeptidyl Peptidase-4 Inhibitor Treatment and the Risk of Bullous Pemphigoid and Other Skin-Related Adverse Events: A Meta-analysis
    Yang, Wenjia
    Cai, Xiaoling
    Zhang, Simin
    Han, Xueyao, Sr.
    Ji, Linong
    DIABETES, 2019, 68
  • [50] Analysis of IL-10 and IL-35 in dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid
    Kokubu, Hiraku
    Takahashi, Toshifumi
    Kabuto, Miho
    Kouzaki, Hideaki
    Fujimoto, Noriki
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (09) : 1569 - 1574
12345